A great way to start off our week 👏 Today, H+C client Sarepta Therapeutics announced positive clinical results from its investigational #genetherapy for the treatment of #limbgirdle #musculardystrophy Type 2E, one of the many subtypes of LGMD that has no treatment options. https://lnkd.in/d4FjPKZ